Superoxide dismutase activity and zinc and copper concentrations in growth retardation

Pelin Aribal Kocatürk1, Güzin Ozelçi Kavas, Omer Erdeve

  • 1Department of Pathophysiology, School of Medicine, Ankara University, Ankara, Turkey.

Insights

Oral zinc treatment improved copper/zinc-superoxide dismutase (Cu/Zn-SOD) activity and normalized zinc and copper levels in children with growth retardation. These findings suggest zinc supplementation can help correct biochemical imbalances associated with growth issues.

Area of Science:

  • Biochemistry
  • Pediatric Nutrition
  • Trace Element Metabolism

Background:

  • Growth retardation is associated with altered copper/zinc-superoxide dismutase (Cu/Zn-SOD) activity.
  • Children with growth retardation often exhibit abnormal zinc and copper concentrations.

Purpose of the Study:

  • To investigate the impact of oral zinc supplementation on Cu/Zn-SOD activity.
  • To assess changes in zinc and copper levels in red blood cells and plasma of children with growth retardation following zinc treatment.

Main Methods:

  • Study included 35 children with growth retardation and 10 healthy controls.
  • Cu/Zn-SOD activity measured using spectrophotometry.
  • Zinc and copper concentrations determined by atomic absorption spectrophotometry.

Main Results:

  • Patients had higher baseline Cu/Zn-SOD activity than controls, which decreased after zinc treatment but remained elevated.
  • Plasma zinc was lower in patients pre-treatment, increasing significantly post-treatment.
  • Red cell zinc increased, while copper levels decreased in both plasma and red cells after zinc supplementation.

Conclusions:

  • Growth retardation is linked to significant disruptions in Cu/Zn-SOD activity and mineral metabolism.
  • Oral zinc treatment effectively normalized plasma and red cell zinc and copper concentrations.
  • Zinc supplementation appears to restore biochemical parameters towards normal ranges in growth-retarded children.

Related Concept Videos